In the fast-paced pharmaceutical industry, competition for talent is fierce. Many companies struggle with high turnover rates and inefficiencies due to outdated or ineffective hiring and onboarding processes not tailored for biopharma. Recent surveys reveal that: The 82% point on
“Building relationships and transparent communication are key to successful outsourcing in cell therapy manufacturing,” says Jessica Brantley, Senior Manager of External Manufacturing at Sonoma Biotherapeutics. Jessica Brantley, brings a wealth of experience from her roles at Novartis and a decade
Luke Bilton is Co-Founder at Life Science Networks Tell us about your background and how you came to launch our company? Before starting Life Science Networks, I spent over 20 years in events and media, with a significant portion in
Firelli Alonso, former Senior Director of External Manufacturing at Pfizer, brings over two decades of experience in the pharmaceutical industry. With a PhD in molecular virology, she has spearheaded viral vaccine development and headed Pfizer’s pre-commercial outsourcing group, focusing on
This report summarises key supply chain events and their expected impact on life science prices over the period September-October 2024. Existing geopolitical tensions and fluctuating commodity stocks are expected to drive global market volatility and supply chain disruptions Contract Development
“Our job is to add value, rather than sell stuff and make money.” – David Anchell, Co-Founder and Managing Director of Camida Camida are a specialist supplier of pharmaceutical raw materials, fine chemicals and intermediates to the life sciences industry,
Antibody-Drug Conjugates (ADCs) – known as ‘the guided missiles of cancer therapy’ – are forecast to drive robust double-digit growth in contract development and manufacturing over the coming years, positioning them as a pivotal force in the biopharmaceutical landscape. ADCs
“We hide behind the hubris of science, but we still have a lot of operational challenges to really impact the lives of our patients,” warns Sanjay Srivastava, Managing Director of Accenture’s Centre of Excellence for Cell & Gene Therapy. This
“Quality oversight isn’t just about compliance – it’s about building successful partnerships and driving down costs,” asserts Stephanie Gaulding, Managing Director at Pharmatech Associates. Stephanie Gaulding, Managing Director at Pharmatech Associates, brings over 30 years of experience in quality management
“What’s in it for the CDMO? That’s the crucial question. We’re not buying a service; we’re establishing a partnership. There has to be interest for both partners.” says Eduardo da Fonseca. Eduardo da Fonseca, Head of Supply Chain at Bioeq,
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
